Influence of the dimension of crystalls on the pharmacological activity and absorption of a new anti-inflammatory composition: phthalazino- (2,3-b) -phthalazine-5, (14H) , 12 (7H) -dione
Beretta, E.; Schiatti, P.; Tenconi, L.T.
Bollettino Chimico Farmaceutico 111(9): 555-560
1972
ISSN/ISBN: 0006-6648 PMID: 4641725 Document Number: 48319
Document emailed within 1 workday
Related Documents
Schiatti, P.; Selva, D.; Arrigoni-Martelli, E.; Lerner, L.J.; Diena, A.; Sardi, A.; Maffii, G. 1974: Antiinflammatory activity and other pharmacological properties of phthalazino(2,3-b)phthalazine-5,12(7H, 14H)-dione (Diftalone) Arzneimittel-Forschung 24(12): 2003-2009Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046
Wojnar, R.J.; Alpaugh, W.C.; Dzelzkalns, E. 1985: Characterization of the anti-inflammatory activity and reduced potential for dermal atrophy of (11 beta, 16 beta)-9-fluoro-1',2',3', 4'-tetrahydro-11,21-dihydroxypregna-1,4-dieno[16,17-b]naph thalene-3, 20-dione hydrate (1 : 1) (SQ 26,490), a topically active corticoid Arzneimittel-Forschung 35(8): 1264-1268
Pedrazzoli, A.; Dall'asta, L.; Maffi, G.; Giudice, A.; Ferrero, E. 1976: Parsalmide: a new anti-inflammatory agent. I. Synthesis and preliminary pharmacological activity of a series of 2-alkyloxy-5-amino-N-alkylbenzamides Bollettino Chimico Farmaceutico 115(2): 125-134
Nakamura, H.; Yokoyama, Y.; Motoyoshi, S.; Ishii, K.; Imazu, C.; Seto, Y.; Kadokawa, T.; Shimizu, M. 1983: The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity Arzneimittel-Forschung 33(11): 1555-1569
Zhu, X.Y.; Wang, W.J.; Xu, G.F.; Yang, Y.L.; Sun, S.M.; Xue, L.M. 1988: The pharmacological activities of musk. II. the anti-inflammatory activity of the active components of musk Yao Xue Xue Bao 23(6): 406-410
Allain, P.; Premel-Cabic, A. 1977: Influence of metals and non-steroid anti-inflammatory drugs on the activity of human red cell ALA dehydratase "in vitro" Pathologie-Biologie 25(8): 535-540
Ahmad, M.; MahayRookh, -; Rehman, A.B.; Muhammad, N.; Amber, -; Younus, M.; Wazir, A. 2014: Assessment of anti-inflammatory, anti-ulcer and neuro-pharmacological activities of Cyperus rotundus Linn Pakistan Journal of Pharmaceutical Sciences 27(6 Spec No.): 2241-2246
Obniska, J.; Pawłowski, M.; Kołaczkowski, M.; Czopek, A.; Duszyńska, B.; Klodzińska, A.; Tatarczyńska, E.; Chojnacka-Wójcik, E. 2003: Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-beta-tetralonepyrrolidine-2,5-dione Polish Journal of Pharmacology 55(4): 553-557
Patel, R.B.; Shah, G.F.; Raval, J.D.; Patel, M.R. 1987: Influence of antidiabetic drugs on the activity of nonsteroidal anti-inflammatory drugs in carrageenan paw edema test in the rat Indian Journal of Physiology and Pharmacology 31(4): 289-292
Tarzia, G.; Occelli, E.; Corsico, N.; Gallico, L.; Luzzani, F.; Barone, D. 1989: Benzodiazepine receptor ligands. Synthesis and preliminary pharmacological evaluation of 2-aminoalkyl-8-chloro- and 2-aryl-1,2,4-triazolo[3,4-a]phthalazine-3(2H)-ones Farmaco 44(1): 17-28
Nagaoka, I.; Ishibashi, Y.; Yamashita, T. 1987: Studies on phytohemagglutinin-induced peritonitis of mice: dynamics of inflammatory responses and influence of anticomplementary agents and anti-inflammatory drugs International Journal of Tissue Reactions 9(3): 179-188
Márquez, M.; Roberts, D.J. 1974: Pharmacological properties of thiazolinobutazone (LAS 11871). I. Anti-inflammatory effects Arzneimittel-Forschung 24(11): 1786-1789
Mascitelli-Coriandoli, E.; Fraia, A. 1970: Prednacinolone, a new anti-inflammatory steroid. 2. Biochemical and pharmacological properties Arzneimittel-Forschung 20(1): 111-115
Lampa, E.; Romano, A.R.; Berrino, L.; Tortora, G.; Di Guglielmo, R.; Filippelli, A.; Gentile, B.; Marmo, E. 1985: Pharmacological properties of a new non-steroidal anti-inflammatory drug: flunoxaprofen Drugs under Experimental and Clinical Research 11(8): 501-509
Iwaki, M.; Oda, M.; Ozeki, M.; Ino, Y.; Suzuki, K.; Koshiyama, Y.; Motoyoshi, A.; Ogihara, M.; Suzuki, S.; Fujita, M. 1984: Pharmacological studies of FUT-175, nafamstat mesilate. III. Anti-inflammatory activities of FUT-175 Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 84(4): 373-384
Wiesenberg-Boettcher, I.; Schweizer, A.; Green, J.R.; Mueller, K.; Maerki, F.; Pfeilschifter, J. 1989: The pharmacological profile of CGP 28238, a novel highly potent anti-inflammatory compound Drugs under Experimental and Clinical Research 15(11-12): 501-509
Okunrobo, L.O.; Usifoh, C.O.; Scriba, G.K.E. 2006: Synthesis and pharmacological evaluation of 2-hydroxymethylbenzamides as anti-inflammatory and analgesic agents Acta Poloniae Pharmaceutica 63(1): 25-31
Chieli, T.; Fregnan, G.B.; Frigerio, L.; Vidali, M. 1976: Toxicity and collateral pharmacological effects of a 3: a new non-steroid anti-inflammatory agent Bollettino Chimico Farmaceutico 115(1): 41-57
Noda, K.; Noguchi, H.; Okui, M.; Tada, K.; Morimoto, Y. 1972: Absorption, distribution, excretion and metabolism of tiaramide hydrochloride: a new anti-inflammatory drug Arzneimittel-Forschung 22(4): 732-743